Library / Regulatory / State map / Kansas
KS · State regulatory reference

Kansas.

Moderate

Kansas takes a conventional, federally-aligned posture. The Kansas Telemedicine Act (K.S.A. 40-2,212, effective 2019) provides that telemedicine may establish a valid provider-patient relationship and applies the same standards as in-person care; prescribing via telemedicine is governed by the same laws as in-person, and K.S.A. 65-28,135 requires an appropriate assessment and documented medical indication. Compounding follows K.A.R. Article 68-13; HB 2068 (2025, signed) adopts USP <795>/<797>/<825>, with no Kansas-specific GLP-1 ban beyond federal 503A. No documented Kansas board enforcement was found.

Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Telemedicine may establish a valid provider-patient relationship and support prescribing under K.S.A. 40-2,212; Kansas defines telemedicine as real-time two-way interactive audio-visual communication (audio-only, email, and fax excluded), and prescribers must conduct an appropriate assessment (K.S.A. 65-28,135).
Compounding
503A compounding follows K.A.R. Article 68-13; HB 2068 (2025) adopts USP <795>/<797>/<825> with Board regulation amendments to conform, and no Kansas-specific GLP-1/semaglutide restriction beyond federal 503A.
Sources
  1. 01 Kansas Telemedicine Act, K.S.A. 40-2,212 (Kansas Revisor of Statutes) ↗
  2. 02 K.S.A. 65-28,135 (telemedicine assessment/prescribing requirement) ↗
  3. 03 Kansas HB 2068 (2025) — adoption of USP compounding standards (Kansas Legislature) ↗
← Back to state map